Review of the increasing evidence supporting early use or preventative use of ivermectin, a well understood and long used anti-parasitic drug. One excerpt below of many discussed. Many places in S. America are using ivermectin and seeing good results.
A fascinating study on the protective role of ivermectin in nursing home residents in France was recently published which found that in a facility that suffered a scabies outbreak, all 69 residents and 52 staff were treated with ivermectin (87). During the time period surrounding this event, 7/69 residents fell ill with COVID-19 (10.1%). In this group with an average age of 90 years, only one resident required oxygen support and no resident died. In a matched control group of residents from surrounding facilities, they found 22.6% of residents fell ill and 4.9% died.
